These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27628319)

  • 21. Expression of Fas and Fas ligand in primary cutaneous squamous cell carcinoma in association with grade of tumor differentiation.
    Lee YB; Kyung Kim E; Park HJ; Cho BK; Park YM; Kim JW; Yoo NJ; Park YG; Oh ST
    Int J Dermatol; 2013 Sep; 52(9):1092-7. PubMed ID: 23045958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression and significance of Fas and FasL protein in squamous cell carcinoma of larynx].
    Shi L; Li G; Zhu C
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Dec; 16(12):661-2. PubMed ID: 12669436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant expression of Fas and FasL pro-apoptotic proteins in basal cell and squamous cell carcinomas.
    Wang XY; Zhang R; Lian S
    Clin Exp Dermatol; 2011 Jan; 36(1):69-76. PubMed ID: 20497185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of fas (CD95) ligand is correlated with IL-10 and granulocyte colony-stimulating factor expression in oral and oropharyngeal squamous cell carcinoma.
    Fujieda S; Sunaga H; Tsuzuki H; Fan GK; Ito T; Sugimoto C; Saito H
    Cancer Lett; 2000 Dec; 161(1):73-81. PubMed ID: 11078915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia].
    Zhang J; Zeng Y; Zheng J; Xu J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
    Shibakita M; Tachibana M; Dhar DK; Kotoh T; Kinugasa S; Kubota H; Masunaga R; Nagasue N
    Clin Cancer Res; 1999 Sep; 5(9):2464-9. PubMed ID: 10499620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis.
    Wu Q; Chen H; Fang J; Xie W; Hong M; Xia L
    Leuk Res; 2012 Mar; 36(3):275-80. PubMed ID: 21917312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The relationship of Fas and Fas L protein expression in oral carcinogenesis].
    Zeng X; Chen Q; Nie M
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Aug; 21(4):259-62. PubMed ID: 14513577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease.
    Adly AA; Ismail EA; Andrawes NG; Mahmoud MM; Eladawy R
    Cytokine; 2016 Mar; 79():52-8. PubMed ID: 26765484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells.
    Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M
    Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade.
    Doll C; Arsenic R; Lage H; Jöhrens K; Hartwig S; Nelson K; Raguse JD
    Anticancer Res; 2015 Nov; 35(11):5867-72. PubMed ID: 26504009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies.
    Abdalla Z; Walsh T; Thakker N; Ward CM
    PLoS One; 2017; 12(12):e0187449. PubMed ID: 29216196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.
    Ebsen H; Lettau M; Kabelitz D; Janssen O
    Mol Immunol; 2015 Jun; 65(2):416-28. PubMed ID: 25745808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
    Erdoğan B; Uzaslan E; Budak F; Karadağ M; Ediger D; Oral B; Göral G; Ege E; Gözü O
    Tuberk Toraks; 2005; 53(2):127-31. PubMed ID: 16100648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of Fas on monocytes and the level of plasma soluble FasL in patients with chronic renal failure].
    Jiang J; Hou F; Liu Z; Liu J; Zhang X
    Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):25-8. PubMed ID: 11798554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Fas and Fas ligand in human testicular germ cell tumours.
    Baldini E; Ulisse S; Marchioni E; Di Benedetto A; Giovannetti G; Petrangeli E; Sentinelli S; Donnorso RP; Reale MG; Mottolese M; Gandini L; Lenzi A; D'Armiento M
    Int J Androl; 2009 Apr; 32(2):123-30. PubMed ID: 17916181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis.
    Sturlese E; Salmeri FM; Retto G; Pizzo A; De Dominici R; Ardita FV; Borrielli I; Licata N; Laganà AS; Sofo V
    J Reprod Immunol; 2011 Dec; 92(1-2):74-81. PubMed ID: 21978769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity.
    de Carvalho-Neto PB; dos Santos M; de Carvalho MB; Mercante AM; dos Santos VP; Severino P; Tajara EH; Louro ID; da Silva-Conforti AM
    PLoS One; 2013; 8(7):e69024. PubMed ID: 23894399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.